Novo Nordisk CEO says company needs bolt-on acquisitions to complement its R&D

NVO•2026-08-05

CEO says bolt-on acquisitions are needed

COPENHAGEN, Aug. 5 (Reuters) - Novo Nordisk CEO Mike Doustdar told journalists on Wednesday he believes the Danish drugmaker needs bolt-on acquisitions to complement its research and development.

Novo Nordisk CEO says company needs bolt-on acquisitions to complement its R&D

CEO says bolt-on acquisitions are needed

Related News

Prologis, Inc. <PLD.N>: RBC Raises to Outperform From Sector Perform; Raises Target Price to $160 From $148

Australia's MEU Says Union Member Fatally Injured In Incident At United Wambo

Yemen's Houthis say they attacked Saudi oil tanker off Yanbu

AMETEK <AME.N>: RBC Raises Target Price to $291 From $260

Global Markets-Stocks up in Asia as tech mood shifts, oil slides